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Yeast Integral Membrane Proteins Apq12, Brl1, and Brr6 Form a
Complex Important for Regulation of Membrane Homeostasis and
Nuclear Pore Complex Biogenesis
Museer A. Lone,a* Aaron E. Atkinson,b Christine A. Hodge,b Stéphanie Cottier,a Fernando Martínez-Montañés,a Shelley Maithel,b*
Laurent Mène-Saffrané,a Charles N. Cole,b Roger Schneitera
Department of Biology, University of Fribourg, Fribourg, Switzerlanda; Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USAb
Proper functioning of intracellular membranes is critical for many cellular processes. A key feature of membranes is their ability
to adapt to changes in environmental conditions by adjusting their composition so as to maintain constant biophysical proper-
ties, including fluidity and flexibility. Similar changes in the biophysical properties of membranes likely occur when intracellular
processes, such as vesicle formation and fusion, require dramatic changes in membrane curvature. Similar modifications must
also be made when nuclear pore complexes (NPCs) are constructed within the existing nuclear membrane, as occurs during in-
terphase in all eukaryotes. Here we report on the role of the essential nuclear envelope/endoplasmic reticulum (NE/ER) protein
Brl1 in regulating the membrane composition of the NE/ER. We show that Brl1 and two other proteins characterized previous-
ly—Brr6, which is closely related to Brl1, and Apq12—function together and are required for lipid homeostasis. All three trans-
membrane proteins are localized to the NE and can be coprecipitated. As has been shown for mutations affecting Brr6 and
Apq12, mutations in Brl1 lead to defects in lipid metabolism, increased sensitivity to drugs that inhibit enzymes involved in lipid
synthesis, and strong genetic interactions with mutations affecting lipid metabolism. Mutations affecting Brl1 or Brr6 or the
absence of Apq12 leads to hyperfluid membranes, because mutant cells are hypersensitive to agents that increase membrane flu-
idity. We suggest that the defects in nuclear pore complex biogenesis and mRNA export seen in these mutants are consequences
of defects in maintaining the biophysical properties of the NE.
The nuclear envelope (NE) of eukaryotic cells compartmental-izes the nuclear material and separates it from the cytoplasm.
The double membrane of the NE consists of an outer and an inner
nuclear membrane (ONM and INM) that differ in protein and
lipid composition. The NE is structurally and functionally related
to the endoplasmic reticulum (ER), and the ONM is contiguous
with the ER (1, 2). Embedded in the NE are the nuclear pore
complexes (NPCs) and, in budding yeast, the spindle pole body
(SPB). NPCs are extremely large and are constructed from multi-
ple copies of about 30 different nucleoporins (nups) (3, 4). NPCs
mediate selective trafficking of proteins and other macromole-
cules between the nucleus and the cytoplasm but also serve other
important functions, including gene activation and mRNA sur-
veillance (5, 6). The biogenesis of NPCs and their distribution
over the NE are highly regulated processes and are coordinated
with the cell cycle (7). During interphase, the number of NPCs
doubles. In budding yeast, the NE remains intact throughout the
cell cycle, and all the formation of NPCs occurs through de novo
construction within the NE.
In addition to the ONM and the INM, the NE contains a pore
membrane domain (POM), formed by the fusion of the INM and
ONM at sites where NPCs are assembled (8). The POM is a highly
curved region of the NE that is intimately associated with nucleo-
porins, including multiple integral membrane nups. Early steps of
the fusion of the inner and outer membrane leaflets of the NE that
accompanies NPC formation require extensive changes in mem-
brane curvature and thus depend directly on lipidic factors, such
as the shape and size of lipid molecules. For example, in vitro
reconstitution experiments using Xenopus egg extracts showed
that pore formation was inhibited by lysophosphatidylcholine,
and this inhibition was completely reversed by the concomitant
addition of oleic acid or phosphatidylethanolamine (9). Inter-
estingly, deletion of membrane-bending reticulons in yeast
cells causes defects in NPC biogenesis. Reticulons have therefore
been regarded as essential factors for proper NPC biogenesis and
distribution (10). Additionally, many NPC proteins, including
yeast Nup85, Nup120, and Nup133, contain amphipathic helical
ALPS (ArfGAP1 lipid-packing sensor) motifs that sense lipid
packaging at the curved membranes of the POM (11). Thus, a
complex array of lipid-protein interactions is thought to stabilize
the highly curved pore membranes, but the roles of these interac-
tions in membrane fusion and curvature are not fully understood
(12, 13).
Recent findings from our labs suggest that NPC biogenesis is
very sensitive to alterations in the membrane composition and
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biophysical properties of the NE/ER. Two integral membrane
proteins of the NE/ER, Apq12 and Brr6, are required for efficient
NPC biogenesis and are implicated in mediating lipid homeostasis
in budding yeast (14, 15). Apq12 was identified in multiple genetic
screens that suggested a possible role in mRNA metabolism, since
the absence of Apq12 led to defects in mRNA export and 3= pre-
mRNA processing (16, 17). Subsequent analysis showed that cells
lacking Apq12 are cold sensitive for growth, exhibit changes in the
membrane properties and morphology of the NE following a shift
to a lower temperature, and are defective in the assembly of NPCs
at nonpermissive temperatures (14).
BBR6 was identified initially in a screen for cold-sensitive mu-
tants affecting mRNA export; depletion of BRR6 led to abnormal-
ities in NPC distribution and NE morphology (18). We identified
BRR6 as a dosage suppressor of the growth and mRNA export
defects seen in apq12 cells and showed that brr6 mutant cells
display defects in nuclear envelope structure and NPC assembly
very similar to those seen in apq12 cells (15). Both the apq12
mutant and the brr6 conditional mutant are hypersensitive to
drugs that inhibit lipid biosynthesis and show synthetically lethal
interactions with mutations in various lipid biosynthetic path-
ways (14, 15). As in the budding yeast, mutations affecting the
orthologous protein of Schizosaccharomyces pombe also lead to
changes in membrane properties (19). These results support the
hypothesis that Brr6 and Apq12 monitor the membrane environ-
ment and coordinate the changes in the lipid composition of the
NE required to maintain optimal function, thereby facilitating the
construction of supramolecular protein complexes such as NPCs
and SPBs (14, 19, 20).
Many fungi, including Saccharomyces cerevisiae, contain a gene
closely related to BRR6 called BRL1. BRL1 was initially identified
in budding yeast as a suppressor of mutations of the nuclear ex-
portin Crm1/Xpo1, which mediates the export of many proteins
and some RNAs from the nucleus (21). Members of the Brr6/Brl1
family of proteins are found in all fungi and lower eukaryotes that
undergo closed mitosis. Whereas S. cerevisiae and many closely
related fungi have both genes, S. pombe, Pneumocystis carinii, and
other fungi distantly related to S. cerevisiae have a unique gene that
is more closely related to Brl1 than to Brr6 (19, 22). Brl1 is not a
nucleoporin; its distribution in the NE is unaffected in strains
carrying nucleoporin mutations that cause NPCs to cluster to-
gether (18, 21). Brr6 and Brl1 of budding yeast show synthetic
genetic interactions. The two proteins have been shown to interact
in a yeast two-hybrid analysis, although it was not determined
how direct their interaction is (21). Interestingly, S. pombe Brr6
has been shown to be required for the insertion of SPBs into the
NE and for NE integrity during the late stages of mitosis (19).
We report here the isolation and characterization of two con-
ditional alleles of BRL1, brl1-1 and brl1-2. We show that these
mutants behave similarly to apq12 and brr6 mutants in causing
defects in mRNA export, NPC biogenesis, and lipid metabolism.
brl1 mutant cells accumulate excess sterols and sterol precursors,
and the synthesis of neutral lipids becomes essential. brl1 mutants
show synthetic lethality with mutations affecting lipid biosyn-
thetic pathways, and the cells are hypersensitive to drugs that
inhibit these pathways and to agents that increase membrane
fluidity.
Our earlier findings with brr6 and apq12 mutants led us to
hypothesize that cells carrying mutations affecting Brr6 and
Apq12 are able to sense a downshift in temperature, leading to
modification of their membrane lipid composition, but are unable
to sense when proper membrane properties have been restored, a
defect that results in hyperfluidization (14, 15). Here we show that
brl1 mutants display all of the phenotypes of brr6 and apq12
mutant cells. Importantly, results from fluidity adaptation exper-
iments provide strong support for the hypothesis that brr6, brl1,
and apq12 mutants overshoot in their compensatory changes.
Upon a temperature downshift, mutants accumulate higher levels
of monounsaturated versus saturated fatty acids, and display a
greater shift to shorter fatty acid chain lengths, than wild-type
(WT) cells. Together, these biochemical and genetic data suggest
that Brl1, Brr6, and Apq12 are candidates for components of a
sensory complex that plays a role in ensuring appropriate altera-
tions in membrane composition needed to maintain the proper
biophysical properties of ER and NE membranes. In support of
the notion that Brl1, Brr6, and Apq12 are components of such a
complex, we find that the proteins partially colocalize in punctate
structures at the NE and can be coprecipitated. The interaction of
Brl1 and Brr6 is reduced in cells lacking Apq12, suggesting that at
least some of these interactions involve an Apq12–Brr6 –Brl1
complex.
MATERIALS AND METHODS
Strains, media, and growth conditions. The strains used in this work are
listed in Table S1 in the supplemental material. Deletion mutants were
obtained by standard yeast transformation protocols using loxP marker
deletion cassettes (23). Strains were grown in YPD rich medium (1%
Bacto yeast extract, 2% Bacto peptone [US Biological, Swampscott, MA],
2% glucose [Reactolab, Servion, Switzerland]) or minimal medium
(0.67% yeast nitrogen base without amino acids [US Biological], 2% glu-
cose, 0.73 g/liter amino acids). To test the sensitivities of mutants to dif-
ferent drugs, strains were grown in minimal or YPD medium; the cultures
were diluted back to a starting optical density at 600 nm (OD600) of 0.2;
and then 1/10 serial dilutions were made. Serial dilutions were spotted
onto plates, which were incubated for 3 to 5 days.
Microscopy. The micrographs in Fig. 1 were recorded using a Nikon
TE2000-E microscope (Nikon 100 Plan Apochromat oil objective; nu-
merical aperture [NA], 1.4), an Orca-ER charge-coupled-device (CCD)
camera (Hamamatsu), and Volocity software, version 5.3.2 (Perkin-
Elmer). To stain lipid droplets (LDs) with 4,4-difluoro-1,3,5,7,8-pen-
tamethyl-4-bora-3a,4a-diaza-s-indacene (BODIPY), cells were incu-
bated with BODIPY 493/503 (Invitrogen, Life Technologies) at a final
concentration of 1 g/ml for 30 min in the dark. Cells were washed
once with phosphate-buffered saline (PBS) containing 50 M bovine
serum albumin (BSA) (fatty acid free) and once with PBS, resuspended
in residual PBS, and analyzed by fluorescence microscopy using a Carl
Zeiss Axioplan 2 microscope (Carl Zeiss, Oberkochen, Germany) fit-
ted with a AxioCam CCD camera and AxioVision software, version
3.1. The genomically tagged proteins shown in Fig. 6 and in Fig. S5 and
S6 in the supplemental material were visualized using a DeltaVision
Elite imaging system (GE Healthcare, Pittsburgh, PA), consisting of an
Olympus 1X71 inverted microscope equipped with a CCD camera
(CoolSNAP HQ2; Photometrics). Images were acquired with a UPlan
S-Apo 100 (NA, 1.4) oil immersion objective (Olympus) and a green
fluorescent protein (GFP)/mCherry filter set. Six to 10 0.2-m-thick
optical sections taken through the nucleus were deconvoluted using
the iterative constrained deconvolution program in softWoRx (Ap-
plied Precision). Single sections are displayed.
Fluorescence in situ hybridization. Cells were grown overnight at
room temperature (RT), back diluted, and allowed to regrow for 4 h
before being shifted overnight to the nonpermissive temperatures (16°C
and 37°C). Room temperature samples were again back diluted the fol-
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lowing day and were allowed to recover for 2 h before all cells were pro-
cessed for in situ hybridization as described previously (24).
Fatty acid analysis. Fatty acid methyl esters (FAMEs) were prepared
from 50 OD600 units of yeast cells. Wild-type and mutant cells were grown
in synthetic complete (SC) medium at 24°C and were diluted to an OD600
of 1. Aliquots were either shifted to 16°C (overnight) or left at 24°C. Cells
were washed once in cold water, and a fatty acid standard (C17:0; 50 g;
Sigma) was added. Cells were disrupted using glass beads, and lipids were
extracted using chloroform-methanol (1:1). FAMEs were produced using
boron trifluoride at 100°C for 45 min and were recovered by extraction
with petrol ether. After evaporation, extracts were resuspended in hexane.
FAMEs were separated with an Agilent 7890A gas chromatograph (GC)
equipped with a DB-23 capillary column (30 m by 250 mm by 0.25 mm;
Agilent Technologies, Santa Clara, CA). The temperature of the injection
port was set to 250°C, its pressure to 26.24 lb/in2 (average velocity, 48.17
cm/s), and the septum purge flow to 3 ml/min. Split injections occurred
through an Agilent 7693A automated liquid sampler. The initial oven
temperature (100°C; held for 2 min) was increased to 160°C at the rate of
25°C/min and was then increased again to 250°C at 8°C/min. The final
oven temperature was held for an additional 4 min. FAMEs were detected
with a flame ionization detector (Agilent Technologies) set at 270°C with
H2, air, and He flows set at 30, 400, and 27.7 ml/min, respectively. FAMEs
were quantified relative to the internal standard, and the relative response
factor for each FAME was determined from a 4-level calibration curve
(r2, 0.999).
Immunoprecipitation (IP). Two liters of YP medium supplemented
with 2% galactose (YPG) was inoculated using a 20-ml YPG culture, and
the mixture was shaken overnight at 24°C. Cells were harvested, resus-
pended in 10 mM HEPES (pH 7.4) and 1.2% polyvinylpyrrolidone, pel-
leted, and frozen in liquid nitrogen. Cells were then homogenized for 3
min in dry ice using commercial coffee grinders and were stored at
80°C. To prepare lysates for immunopurification, 2 g of the homoge-
nized cell powder was added to 4 ml of lysis buffer composed of 20 mM
HEPES (pH 7.4), 110 mM potassium acetate, 150 mM sodium chloride, 2
mM magnesium chloride, 1 mM EDTA, 1% filtered Triton X-100
(SLHV033RS filter; pore size, 0.45 m; Millipore), and protease inhibi-
tors (product no. 11836170001; Roche). The ground cells were then re-
suspended, chilled on ice for 10 min, and clarified with a low-speed spin at
3,200 relative centrifugal force (RCF). The soluble lysate was transferred
to a fresh tube; load fractions were taken; and 40 l of anti-GFP or anti-
Myc magnetic beads was added to the remaining suspension (catalog no.
D153-9 and M047-1; Medical & Biological Laboratories). Lysate bead
slurries were rotated at 4°C for 2 h. The beads were then pelleted on ice
using magnetic racks and were rinsed 3 times with 0.5 ml of the remaining
cold lysis buffer. Proteins were eluted off beads with SDS loading buffer,
and immunoblotting was performed by standard methods. GFP-tagged
proteins were detected with a rabbit-raised anti-GFP antibody provided
by Bill Wickner. Hemagglutinin (HA)-tagged proteins were detected with
a mouse monoclonal antibody (H9658; Sigma). Myc epitopes were de-
tected with an anti-c-Myc mouse monoclonal antibody (9E10; Santa Cruz
Biotechnology). Yet3 was detected with a rabbit-raised anti-Yet3 antibody
given to us by Charlie Barlowe.
RESULTS
Growth, mRNA export, and NPC assembly defects of brl1 mu-
tants. To study Brl1 functions, we isolated two brl1 alleles follow-
ing error-prone PCR and screening for cold- and heat-sensitive
growth. The brl1-1 mutant is temperature sensitive and fails to
grow at 37°C. As seen previously with the brr6-1 mutant, the brl1-2
mutant exhibits limited growth at 23°C and fails to grow at either
16°C or 37°C, indicating that this allele is sensitive to both cold
and heat. brr6-1, brl1-1, and brl1-2 cells grow best at 30°C, al-
though none of them grows as well as the wild type at this temper-
ature (Fig. 1A).
We next performed in situ hybridization analysis to localize
poly(A) RNA in mutant cells. brl1-1 cells do not accumulate
poly(A) RNA in nuclei when grown at either 16°C or room tem-
perature, two conditions under which mutant cells can grow.
However, when shifted to 37°C, brl1-1 cells showed moderate ac-
cumulation of poly(A) RNA in nuclei, indicating a defect in
mRNA export. The brl1-2 mutant was more defective for mRNA
export when grown at 16°C, 23°C, and 37°C, temperatures at
which it either fails to grow or shows very limited growth (Fig. 1B).
The effects of brl1 mutations on NPC assembly and distribu-
tion were assessed by localizing two GFP-tagged nucleoporins,
Nup60 and Nup82. Brl1 mutant cells displayed a near-normal
distribution of Nup60-GFP, a component of the nuclear basket of
NPCs, but may have a mild NPC clustering phenotype (Fig. 1C)
(21). In contrast, Nup82-GFP, a component of the cytoplasmic
filaments (CFs), lacked signal at the nuclear periphery and dis-
played aberrant localization in large punctate structures in the brl1
mutants, indicating that NPC assembly is defective in these mu-
tants (Fig. 1C). Taken together, these results demonstrate that
Brl1 is essential for growth, NPC assembly, and optimal mRNA
export. In this respect, brl1 mutants closely resemble brr6-1 and
FIG 1 Mutants with mutations in Brl1 are temperature sensitive and affect
mRNA export and NPC assembly and distribution. (A) Temperature sensitiv-
ity of brl1 mutant strains. Cells were grown at 30°C in YPD, and serial dilutions
were spotted onto YPD plates. (B) Mutations in Brl1 affect mRNA export.
Cells were incubated at the indicated temperatures for 18 h, and the subcellular
distribution of poly(A) mRNA was analyzed by in situ hybridization. DNA
was stained with DAPI. (C) Brl1 affects the distribution and assembly of the
NPC. The distribution of the nuclear basket protein Nup60-GFP and that of
Nup82-GFP, a component of the cytoplasmic filaments, were analyzed by
fluorescence microscopy. Bar, 5 m.
Lipids Affect the Nuclear Pore Complex
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apq12 mutants. These three types of mutants are referred to
collectively below as BBA mutants and their protein products as
BBA proteins.
Defects in sterol metabolism and genetic interactions in brl1
mutant cells. Given the high degree of similarity between brl1 and
brr6 mutants, including the shared defects in growth and mRNA
export, as well as nucleoporin mislocalization, it was not surpris-
ing to find that brl1 mutants also have defects very similar to those
we reported for brr6-1 and apq12 mutants with respect to lipid
metabolism, sensitivity to drugs that inhibit lipid biosynthetic
pathways, and genetic interactions with genes encoding enzymes
involved in lipid biosynthesis (14, 15).
Mutants with mutations that directly affect ergosterol metab-
olism or indirectly disturb sterol homeostasis are often hypersen-
sitive to inhibitors of sterol biosynthetic enzymes. brl1 mutants
were hypersensitive to drugs that inhibit sterol biosynthesis (ter-
binafine, fenpropimorph, and fluconazole) even at 30°C, their op-
timal growth temperature (Fig. 2A). In accordance with the drug
sensitivity observed, brl1 mutations exhibited strong aggravating
genetic interactions with mutations in sterol biosynthesis and
transport (erg5, erg6, arv1) (Table 1).
brl1 mutants also displayed much higher levels of the sterol
ergosterol and its precursors than wild-type cells (see Fig. S1A and
B in the supplemental material). We previously identified BRR6 as
a dosage suppressor of the cold-sensitive growth and mRNA ex-
port defects of apq12 cells and, conversely, showed that overex-
pression of Apq12 partially suppressed the defects in mRNA ex-
port, NPC biogenesis, and aberrant sterol accumulation exhibited
by brr6 cells (15). We found that overexpression of APQ12 or
BRR6 restores wild-type levels of both ergosterol and episterol in
both brl1 mutants (see Fig. S2A to D in the supplemental mate-
rial). Likewise, overexpression of wild-type BRL1 or APQ12 de-
creased the levels of these sterols in a brr6 background (see Fig. S2E
and F in the supplemental material). These data indicate that the
three BBA proteins share a function in sterol homeostasis, since
overexpression of any one of them can suppress the altered sterol
phenotype induced by mutations in the other genes.
Neutral lipid synthesis is essential for brl1 mutants. Yeast
and mammalian cells esterify sterols to form steryl esters (STE),
which are removed from membranes and packaged into lipid
droplets (LDs). In addition to STE, LDs also contain high levels of
triacylglycerols (TAG). Storage of STE and TAG in LDs allows
cells to sequester both free sterols and free fatty acids and thus
suppress the toxicity associated with the accumulation of these
lipids. These neutral lipids can be mobilized rapidly when cells
need to form new membranes, for example, upon the resumption
of growth following dilution into fresh medium. STE levels were
considerably higher in brl1 mutant cells than in wild-type cells (see
Fig. S3 in the supplemental material).
The overproduction of STE in brl1 mutants prompted us to
look for any alterations in the number or morphology of LDs in
these cells. LDs were stained with the neutral lipid-staining dye
BODIPY 493/503, and the average number of LDs per cell was
determined. In wild-type cells, LDs remained connected to the ER
membrane but appeared to be distributed throughout the cell
(25). In wild-type cells, the average numbers of LDs differed de-
pending on the growth phase, reaching 4 to 6 per cell in exponen-
tially growing cells. The number of LDs in brl1 mutants increased
about 1.5-fold to reach about 10 per cell (Fig. 2B). Strikingly, LDs
in the brl1 mutants were often arranged in a circular fashion, co-
inciding with the NE/ER, as indicated by their colocalization with
the ER marker Kar2-RFP-HDEL (Fig. 2B). These observations are
similar to those reported for brr6-1 (15).
Since both brl1 mutants incorporate more fatty acids into STE,
have higher numbers of LDs per cell, and display aberrant perinu-
clear accumulation of LDs, we wondered whether the increased
synthesis of neutral lipids is important for the growth and survival
of these mutants. The synthesis of these neutral lipids depends on
the activities of four acyltransferases: two, Lro1 and Dga1, for
TAG synthesis and two, Are1 and Are2, for STE synthesis (26).
Neutral lipid synthesis and LD formation are nonessential in
yeast under normal growth conditions. Indeed, yeast cells car-
TABLE 1 Genetic interactions of brl1 mutationsa with mutations
affecting lipid biosynthesis
Genotype of lipid
mutant tested Function of encoded proteinb Interactionc
elo2 Fatty acid elongation SL
elo3 Fatty acid elongation SL
arv1 Sterol homeostasis, GPI anchor synthesis SL
erg5 Ergosterol biosynthesis SL
erg6 Ergosterol biosynthesis SL
mga2 Transcription factor for OLE1 SS
spt23 Transcription factor for OLE1 SS
a The brl1-1 and brl1-2 mutants show similar interactions with the mutants listed. The
growth of the double mutants was assessed at 30°C.
b GPI, glycosylphosphatidylinositol.
c SL, synthetically lethal; SS, synthetically sick.
FIG 2 brl1 mutants have defects in sterol homeostasis. (A) Hypersensitivity of
brl1 mutant cells to inhibitors of sterol biosynthesis. Serial dilutions of wild-
type, brl1, and brr6 strains were spotted onto SC plates containing the indi-
cated concentration of fenpropimorph (Fen), terbinafine (Terb), or flucona-
zole (Flu), and plates were incubated at 30°C. (B) brl1 cells accumulate lipid
droplets (LDs) and have aberrant LD morphology. Cells of the indicated ge-
notypes were grown in SC medium, and LDs were stained with BODIPY 493/
503. Colocalization with the ER marker Kar2-mRFP-HDEL reveals perinu-
clear clustering of LDs in brl1 cells. The average number of LDs  the standard
deviation of the mean (n, 100 cells) is given for each genotype. Bar, 5 m. (C)
brl1 mutants are synthetically lethal with mutants that fail to synthesize TAG
(dga1 lro1 mutants) or STE (are1 are2 mutants). brl1 mutant cells res-
cued by a plasmid-borne wild-type copy of BRL1 (URA3) were deleted for the
indicated neutral-lipid biosynthetic gene, and loss of the wild-type copy of
BRL1 was assessed on plates containing 5-fluoroorotic acid (5-FOA).
Lone et al.
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rying double deletions of dga1 and lro1 or of are1 and are2 have
very few or no LDs yet are viable. Similarly, cells carrying de-
letions of all four of these acyltransferases have no LDs and are
also viable (27). We reported previously that the formation of
neutral lipids is essential for the viability of brr6 cells (15). This
is also the case for brl1, since triple mutant cells combining a
brl1 mutation with either dga1 and lro1 mutations or are1
and are2 mutations can grow only if a wild-type copy of BRL1
(pBRL1) is present (Fig. 2C).
We also examined genetic interactions between brl1 mu-
tants and mutations affecting genes involved in fatty acid me-
tabolism. We found that the brl1 alleles are synthetically lethal
with mutations of genes whose products are involved in fatty
acid elongation (elo2, elo3) and synthetically sick with
mutations affecting the regulation of fatty acid desaturation
(mga2, spt23) (Table 1).
The ability to adapt rapidly to changes in membrane properties
brought about by changes in temperature or by the addition of
agents that fluidize membranes is essential for viability. We re-
ported previously that both brr6-1 and apq12 mutants were hy-
persensitive to benzyl alcohol (BA) and to oleic acid, a major un-
saturated fatty acid of yeast (15). We compared the growth of brl1
mutant cells with that of brr6-1and apq12 cells in the presence of
BA or oleic acid. All strains were hypersensitive to both BA and
oleic acid (15) (Fig. 3A). Interestingly, cells unable to make neutral
lipids (STE and TAG) were also hypersensitive to BA, indicating
that the ability to store neutral lipids in LDs is also essential when
cells are adjusting to the increased fluidity caused by the addition
of BA (Fig. 3B).
Analysis of membrane lipid composition in WT, brl1, brr6,
and apq12 cells suggests that mutants are defective in the reg-
ulation of membrane properties. We wanted to test the hypoth-
esis that the hypersensitivity of BBA mutants to BA and oleic acid,
the observed alterations in lipid metabolism, and the synthetic
lethality of these mutants with mutations in genes needed for neu-
tral lipid synthesis reflect misregulation of the adaptation of mem-
branes to temperature or BA. When cells are shifted to a lower
temperature, membranes become more rigid until changes in
membrane lipid composition needed to restore membrane ho-
meostasis take place. Because substantial changes in lipid compo-
sition occur after a temperature downshift of the BBA mutants, we
conclude that the mutant cells sense the temperature change, lead-
ing to alterations in lipid metabolism. A proper response that
would restore normal fluidity would be to increase the level of
monounsaturated fatty acids and to shift the membrane fatty acid
profile toward shorter chain lengths.
We analyzed the levels and composition of total fatty acids in
BBA mutant cells at different temperatures. Exponentially grow-
ing cells were shifted from 24°C to 16°C for 16 h. Control cells
were maintained at 24°C. Lipids were extracted, and fatty acid
methyl esters (FAMEs) were analyzed by gas chromatography
(GC) and quantified relative to internal standards. As expected,
following a shift to 16°C, levels of the monounsaturated fatty acids
palmitoleic acid (C16:1) and oleic acid (C18:1) increased in both
wild-type and brl1 mutant cells, but to a much greater extent in
mutant than in wild-type cells (Fig. 4A and B). Following this shift,
the difference in the levels of oleic acid (C18:1) between the mu-
tants and the wild type was most pronounced for brr6 cells but was
also observed for the other mutants. Levels of the short-chain fatty
FIG 3 brl1 mutant cells are hypersensitive to the membrane-fluidizing agents
oleic acid and benzyl alcohol. (A) Hypersensitivity of brl1 mutant cells to
membrane-fluidizing agents. Strains were grown in YPD; 10-fold serial dilu-
tions were spotted onto plates containing the indicated concentration of oleic
acid or BA; and plates were incubated at 30°C. The hypersensitivity of brl1 and
brr6 mutant strains to these agents is indicative of hyperfluid membranes and
deregulation of membrane composition. (B) Mutants lacking the capacity to
synthesize neutral lipids are hypersensitive to BA. The indicated strains were
cultured in YPD, diluted, and spotted onto plates containing the indicated
concentration of BA.
FIG 4 brl1, brr6, and apq12 mutant cells accumulate short-chain and unsat-
urated fatty acids. Cells were cultivated at the indicated temperatures in SC
medium for 16 h; lipids were extracted; and fatty acid methyl esters were
analyzed by GC using C17:0 as an internal standard. Palmitoleic acid (A) and
oleic acid (B) levels are increased at 16°C, as are the levels of the C14 short-chain
fatty acids myristic acid (C) and myristoleic acid (D). Palmitic acid (E) and
stearic acid (F) levels are affected in the brr6-1 mutant. Values are means 
standard deviations for at least two independent experiments.
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acid myristic acid (C14:0) and its desaturated form, myristoleic
acid (C14:1), were considerably higher in BBA mutant cells than in
wild-type cells, particularly at 16°C (Fig. 4C and D). Levels of the
saturated fatty acids palmitic acid (C16:0) and stearic acid (C18:0)
were increased in brr6-1 cells at 16°C, but overall they displayed
the least temperature-induced change (Fig. 4E and F).
Taken together, these data show that cells carrying mutations
affecting the BBA proteins have much higher levels of monoun-
saturated and shorter-chain fatty acids than wild-type cells. There
was a 3-fold increase in the level of myristoleic acid, in addition to
higher levels of myristic and palmitoleic acids. In addition, in mu-
tant cells, there was a shift toward shorter-chain fatty acids, with
the greatest increase occurring for myristic acid (C14:0). The in-
creased levels of these fatty acids at 16°C confirm that mutant cells
can sense the shift to a lower temperature and attempt to restore
membrane homeostasis by altering membrane lipid composition.
Importantly, and supporting our hypothesis, the altered fatty acid
profiles observed in mutant cells indicate that the changes in lipid
composition move these cells in the right direction but that they
incorporate into their membranes excessive levels of these short-
er-chain and monounsaturated fatty acids, thereby rendering
their membranes too fluid.
brl1 mutants display defects in homeoviscous adaptation af-
ter treatment with and withdrawal of benzyl alcohol. The studies
presented above indicate that membranes in mutant cells acquire
a fatty acid composition that would be expected to render them
more fluid than optimal following a shift to 16°C. We wondered
how the mutants would modify their membrane lipid composi-
tion under conditions where BA rather than temperature was used
to induce a shift in composition. Following the addition of BA,
membranes would become too fluid until they were able to restore
appropriate membrane lipid composition. In this case, restoration
of normal fluidity requires a shift to longer fatty acid chain lengths
and reductions in the levels of monounsaturated fatty acids. Fol-
lowing the withdrawal of BA, membrane lipid composition would
be expected to return to approximately the levels that cells showed
before BA treatment.
Interestingly, there have been no reports on the effects of BA on
the fatty acid or sterol composition of cells. Because brl1 and brr6
mutant cells are sensitive to BA, possibly due to a failure to control
membrane fluidization, we carried out fatty acid and sterol anal-
yses of wild-type cells after treatment with BA at 24°C. Following
dilution to restore exponential growth, the cells were exposed to
BA and were maintained at 24°C. As expected, following the ad-
dition of BA, wild-type cells showed substantial decreases in the
levels of C14:0 and C14:1 fatty acids and increased levels of mem-
brane-rigidifying stearic acid (Fig. 5A to C). The levels of C16:0 and
C18:1 fatty acids did not differ from those in untreated cells (not
shown). When sterols were analyzed, an increase in ergosterol
levels following BA treatment was also observed, in accordance
with an adjustment to make membranes more rigid (Fig. 5D).
To test the hypothesis that the brl1 mutants overcompensate in
their adaptive changes, we analyzed fatty acid changes in BA-
treated brl1-1 cells. Data were normalized to the levels each strain
showed prior to treatment with BA. Following BA treatment for 5
h, mutant cells showed smaller reductions in the levels of C14:0 and
C14:1 fatty acids than wild-type cells, suggesting that they were
unable to adapt fully to the addition of BA. During their recovery
after BA was removed, wild-type cells increased their short-chain
C14 fatty acid levels to 55% to 72% of their initial levels within 10
h after BA withdrawal (72% for C14:0 and 55% for C14:1). In con-
trast, brl1-1 cells reached 127% of the initial level of C14:0 and
119% of the initial level of C14:1 (Fig. 5E and F). This indicates that
this mutant overcompensates and, within 10 h, reaches C14 levels
almost twice as high as those present in similarly treated wild-type
cells. Similar, albeit less pronounced, overcompensation was also
observed for the C16 and C18 fatty acids (see Fig. S4 in the supple-
mental material) and in the brl1-2 mutant (data not shown). We
conclude that brl1 mutant cells not only sense and respond to BA
removal but incorrectly adjust their fatty acid composition to lev-
els expected to cause excess rigidity. The data support the hypoth-
esis that this mutant is defective in homeostatic adaptation of
membrane fatty acid composition.
Brl1 localizes to punctate structures within the nuclear enve-
lope and is present in a common complex with Brr6 and Apq12.
Brr6 and Brl1 are low-abundance proteins, and in previous stud-
ies, overexpression was used to permit easy detection of these pro-
teins fused to GFP (18, 21, 28). Overexpressed tagged proteins
were found primarily in the NE/ER. In an effort to localize them
more accurately, we used a highly sensitive microscope setup to
localize GFP-tagged versions of the proteins expressed from their
normal genomic locations (Fig. 6A). Brl1-GFP localized to a few
FIG 5 Adaptive changes in lipid profiles of wild-type and brl1 mutant cells
upon treatment with benzyl alcohol. Wild-type cultures grown at 24°C in SC
medium were split, diluted to an OD600 of 0.25, and either left untreated or
treated with a sublethal dose of BA (0.2%). Cultures with equal ODs were
harvested at the indicated time points; lipids were extracted; and fatty acids
and sterols were analyzed. Wild-type cells treated with BA show lower levels of
the short-chain C14 fatty acids myristic acid (A) and myristoleic acid (B), with
concomitant increases in the levels of the long-chain C18:0 saturated fatty acid
stearic acid (C) and ergosterol (D). These changes are probably induced to
counteract the fluidizing effect of BA. (E and F) Recovery of wild-type and
brl1-1 mutant cells from treatment with BA. Cells were cultivated at 24°C and
were treated with BA (0.2%) for 5 h. Cells were washed with fresh medium and
were recultivated for another 5 h or 10 h. Lipids were extracted, and fatty acid
profiles were recorded by GC and were plotted relative to the levels present at
the zero time point. Values are means  standard deviations for three inde-
pendent experiments.
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puncta at the NE, whereas Brr6-GFP displayed a more uniform
distribution of puncta over the NE. Apq12, on the other hand,
appeared to be localized both to the NE and throughout the ER.
This pattern of localization, particularly that of Brr6, resembles
the distribution of NPCs, as displayed by Nup84-GFP (Fig. 6A).
However, Apq12, Brl1, and Brr6 did not display clustering when
analyzed in a nup120 mutant background, a strain where NPCs
are localized to one or two clusters within the NE (29) (Fig. 6A).
Furthermore, puncta containing Brl1 or Brr6 did not display
stringent colocalization with the SPB marker Spc42 (Fig. 6A). In
cells synchronized by treatment with 	-factor, however, partial
colocalization of Brl1 and Brr6 with the SPB could be observed
(see Fig. S5 in the supplemental material). Interestingly, Brl1 and
Brr6 partially colocalized in punctate structures, suggesting that
they may associate with each other (Fig. 6A). The punctate local-
ization of Brr6 and Brl1 in the NE was not affected in cells treated
with BA, nor did BA affect the colocalization of these two proteins
(see Fig. S6 in the supplemental material).
Given that BBA mutant cells display many common pheno-
types, we wondered whether the three proteins might interact
physically with each other to form a complex. To test this, tagged
versions of these proteins were immunoprecipitated, and the pres-
ence of the other proteins was detected by Western blotting. These
experiments revealed that both Brr6-HA and Brl1-HA, but not
Yet3, another transmembrane protein of the NE/ER (30), could be
detected when Apq12-GFP was immunoprecipitated (Fig. 6B).
Similarly, a pulldown of Brr6 –13Myc coprecipitated Brl1-HA in
wild-type cells (Fig. 6C). Interestingly, if the co-IP was performed
in an apq12 mutant strain, significantly less Brl1-HA was copre-
cipitated with Brr6 –13Myc. These data suggest that there may be
complexes containing all three BBA proteins as well as some that
contain two BBA proteins. These findings are consistent with
those of Saitoh et al., who reported earlier that a Brl1–Brr6 inter-
action could be detected using a two-hybrid system (21).
DISCUSSION
The lipid composition of cellular membranes is a major determi-
nant of their biophysical properties. In response to temperature
changes, cells modify the composition of their membranes so as to
maintain membrane function, a process known as homeoviscous
adaptation (31, 32). The processes by which the cell senses the
need to modify lipid composition and assesses when the appro-
priate composition has been attained are complex and are best
characterized in model prokaryotes (33, 34). For example, shifting
cells to a lower temperature causes membranes to become more
rigid, and this increased rigidity triggers changes in membrane
lipid composition leading to the restoration of normal fluidity and
flexibility. Changes in lipid composition also occur following heat
shock (35). Recently, it was shown that heat shock induces activa-
tion of the gene encoding acyl coenzyme A (acyl-CoA) dehydro-
genase, which then controls lipid saturation levels and hence
membrane fluidity in Caenorhabditis elegans (36). It is not known
how the cell senses the need to induce this enzyme. Although
medium-chain dehydrogenases are essential enzymes for the deg-
radation of fatty acids through mitochondrial beta-oxidation and
are present in humans, it is not known if these enzymes are in-
duced by the same mechanism in humans as they are in C. elegans.
In yeast, on the other hand, there is no mitochondrial homolog of
the C. elegans enzyme, possibly because beta-oxidation of medi-
um-chain fatty acids is confined to peroxisomes.
Fusion of the inner and outer nuclear membranes is a key
event in NPC biogenesis. NPCs are essential for the proper func-
tioning of eukaryotic cells. During each cell cycle, the number of
NPCs is doubled as new NPCs are constructed within the double
membrane of the NE. Although highly symmetrical and built
from only 30 different proteins, the NPC has a mass of approxi-
mately 60 MDa and contains several hundred nucleoporins (3, 4).
Construction is likely to be complex, since it requires fusion of the
inner and outer nuclear membranes, creating a membrane do-
main called the pore membrane, the part of the NE that is in close
contact with the NPC. The pore membrane contains transmem-
brane nucleoporins that play an essential role in anchoring the
NPC within the nuclear envelope.
In eukaryotic cells, most membrane fusion events occur
through the action of SNARE complexes that mediate the apposi-
tion of two membranes and then accomplish the task of fusing the
inner and outer leaflets of the membranes (37). Membrane fusion
during NPC biogenesis does not involve the action of SNARE
complexes. Neither the mechanics of this membrane fusion event
nor the stage during NPC biogenesis at which fusion occurs has
been determined. However, NPC biogenesis requires that the pore
membrane domain become highly curved (38). Successful fusion
results in the formation of a protein-membrane tunnel that con-
nects the nucleoplasm and the cytoplasm and provides a gated
aqueous channel through which nucleocytoplasmic trafficking
takes place.
NPCs contain several proteins that have transmembrane do-
mains. Among these, only Ndc1 is essential, and it is the only
nucleoporin also found in the SPB (39). All other integral mem-
brane nucleoporins are not essential, but generally only a single
one can be absent. It has also been shown that targeting of Pom33,
an integral membrane nucleoporin, to the NPC requires its am-
phipathic helices, which preferentially bind to highly curved
membranes (12). Also implicated in NPC biogenesis are the re-
ticulons, which are able to induce membrane curvature and have
been shown to be important for the formation of tubule structures
of the ER (40). Deletion of both RTN1 and YOP1, encoding two of
the reticulons of S. cerevisiae, causes defects in nucleoporin local-
ization and NPC distribution within the NE (10). In metazoan
cells, reticulons are required for proper reassembly of the NE fol-
lowing mitosis (41, 42). Using a Xenopus laevis in vitro system
where de novo assembly of new NPCs takes place, Dawson et al.
FIG 6 Brl1 localizes in punctate structures within the NE and interacts with Brr6 and Apq12. (A) Brl1-GFP localizes to a few puncta within the NE. Cells of the
indicated genotypes were cultivated to the mid-log phase (OD600, 1 to 2) at 30°C, except in the experiment performed with nup120 mutants (24°C), and were
analyzed by fluorescence microcopy. All proteins visualized in this panel have been tagged at their carboxy termini. Colocalization is indicated by arrows. Bar, 5
m. (B) Brl1 interacts with Brr6 and Apq12. Lysates from cells expressing Apq12-GFP, Brr6-HA, and Brl1-HA (load) were immunoprecipitated with antibodies
against GFP. Immunopurified fractions were analyzed by Western blotting for the presence of Brr6-HA and Brl1-HA (IP). The yeast endoplasmic reticulum
transmembrane protein 3 (Yet3) served as a loading control. (C) Lysates from cells expressing Brr6 –13Myc (load) were immunoprecipitated (precipitate) with
antibodies against the Myc epitope. Fractions were analyzed by Western blotting for the presence of Brr6 –13Myc and Brl1-HA, in the presence and absence of
Apq12. The presence of the 13Myc tag shifts the molecular mass of Brr6 by 15.6 kDa.
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(2009) showed that addition of an anti-reticulon antibody to the
system led to a block in the assembly of new NPCs (10). Previ-
ously, it had been shown that this antibody did not affect the
normal expansion of the NE that occurs during the reassembly of
nuclei in Xenopus egg extracts, suggesting a specific role for this
reticulon in NPC biogenesis.
While some nucleoporins and reticulons are able to bind to
and stabilize curved membranes, successful membrane bending
and fusion likely require modifications to the biophysical proper-
ties of the nuclear membranes at sites of NPC formation, provid-
ing locally increased flexibility and fluidity in the pore membrane
domain during the actual membrane fusion events. It is not
known how these alterations in membrane properties are regu-
lated, but they could be induced as a response to the initial curva-
ture that would result from the interaction of reticulons and some
nucleoporins with the nuclear membranes during NPC forma-
tion.
Nups comprising the cytoplasmic filaments (CFs) of the yeast
NPC were mislocalized to bright cytoplasmic foci in cells carrying
mutant alleles of the genes encoding BBA proteins (14, 15) (Fig.
1). The mislocalized nups were sometimes associated with the
cytoplasmic face of the NE. In contrast, we saw normal localiza-
tion for all nuclear basket nups and limited mislocalization of a
subset of central framework nups. Experiments to distinguish be-
tween defects in NPC assembly and NPC stability in apq12 and
brr6-1 cells indicated that NPC assembly was affected by the mu-
tations to a much greater degree than the stability of pores formed
prior to the shift to a nonpermissive temperature (14, 15). One
model that fits with these observations is that NPC assembly might
be initiated within the inner nuclear membrane, while the CF
nups might be incorporated late during NPC biogenesis. We spec-
ulate that membrane fusion events that are part of NPC biogenesis
also occur late during NPC assembly and might be required for the
incorporation of the CFs as a final step in NPC biogenesis.
Mutations affecting any of the three BBA proteins lead to mod-
est defects in mRNA export that likely result indirectly from de-
fects in NPC biogenesis (14, 15) (Fig. 1). These proteins, particu-
larly Brl1, appear to be involved in SPB biogenesis also (19). In S.
cerevisiae and S. pombe, SPB biogenesis involves the construction
of a new SPB adjacent to the NE, on its cytoplasmic side, followed
by insertion of this structure into the NE.
We identified physical interactions among the three BBA pro-
teins, with both Brl1 and Brr6 coprecipitating with Apq12 (Fig.
6B). This is consistent with the presence of binary Apq12–Brl1 and
Apq12–Brr6 complexes, as well as with a ternary complex contain-
ing all three proteins. Because the levels of Brr6 and Brl1 that can
be coprecipitated are reduced when Apq12 is missing, we think it
likely that at least some fraction of these proteins forms a ternary
complex. Our data do not indicate how direct the interactions
among Brl1, Brr6, and Apq12 are. However, these interactions
likely underlie some of the similar phenotypes seen with brl1 and
brr6 mutants.
Possible roles for Brl1, Brr6, and Apq12. After either a shift of
mutant cells to a low temperature or recovery from BA treatment,
high levels of sterols could be needed to compensate for the in-
creased levels of shorter-chain and monounsaturated fatty acids
(Fig. 4 and 5). While BBA mutant cells are able to sense the need to
modify membrane properties following a temperature downshift
or in response to the addition or removal of BA, their sensitivity to
oleic acid and the membrane-fluidizing agent BA suggests that
they are unable to detect when proper membrane homeostasis has
been restored. This defect results in hyperfluidization of mem-
branes in mutant cells shifted to lower temperatures.
We found that cells respond to the addition of BA by adjusting
their membrane composition in an effort to restore membrane
homeostasis. In wild-type cells, levels of C14:0 and C14:1 fatty acids
decrease, and levels of stearic acid (C18:0) and ergosterol increase
(Fig. 5A to D). Wild-type cells thus respond to membrane fluidi-
zation by BA with compensatory changes in their membrane lipid
composition. When BA is removed, wild-type cells respond with
appropriate adjustments in membrane lipid composition.
In contrast, brl1, brr6, and apq12 cells are defective in con-
trolling these alterations. In response to low temperatures, their
membranes acquire a composition that would be expected to
cause excessive fluidity. In response to BA, their membranes ap-
pear to become excessively fluid. During recovery from BA treat-
ment, C14:0 and C14:1 levels in brl1-1 mutant cells increased, and
the increase was much greater than that in wild-type cells (Fig. 5E
and F). This altered adaptive response supports the hypothesis
that the BBA mutants are able to sense reduced temperatures or
the addition/removal of BA and that they induce changes in their
lipid composition. However, they appear unable to assess when
proper membrane fluidity has been restored and thus continue to
produce lipids that enhance fluidization. One possibility is that
mutant cells are defective in the function of some “fluidity regu-
lator” such that the cells become hypersensitive to BA, oleic acid,
or a temperature downshift.
This aberrant response to BA, as well as the increased levels of
unsaturated fatty acids at all temperatures tested, might suggest
that the activity of the fatty acid desaturase Ole1 is affected by the
mutation of BRL1 and BRR6 (Fig. 4 and 5). OLE1 expression is
regulated by two transcription factors, Mga2 and Spt23, in re-
sponse to environmental conditions, such as temperature, oxygen
levels, and the presence of unsaturated fatty acids in the medium
(43). Spt23 and Mga2 are not essential but redundant, since dele-
tion of either gene has little effect on the transcription of OLE1,
but deletion of both results in synthetic lethality due to the inabil-
ity of cells to produce Ole1 (44). Interestingly, mutants of Brl1 and
Brr6 are synthetically sick with the deletion of either Mga2 or
Spt23, in accordance with enhanced dependence on Ole1 function
in these mutants (Table 1).
The biophysical properties of cellular membranes reflect both
the degree of fatty acid desaturation and the distribution of fatty
acid chain lengths. In principle, short-chain fatty acids should act
synergistically with monounsaturated fatty acids in enhancing
membrane fluidity. The regulation of both is defective in the BBA
mutants. Our findings indicate that Brl1, Brr6, and Apq12 impact
multiple key points in lipid metabolism that normally allow cells
to maintain lipid homeostasis at the NE/ER membrane.
Link between lipid metabolism and NPC biogenesis. Several
observations link lipid synthesis specifically with the morphology
of the NE as well as with the biogenesis of NPCs and the SPB. AccI
(acetyl-CoA carboxylase) catalyzes the first step of fatty acid bio-
synthesis. A mutant allele of ACC1 was identified in a screen for
mutants with mutations in genes whose products were required
for efficient mRNA export. Mutations affecting AccI also lead to
changes in NE morphology and defects in NPC biogenesis
(45–47). In budding yeast, inactivation of the Nem1–Spo7 phos-
phatase complex and its effector protein, Pah1 (phosphatidic acid
phosphohydrolase 1), leads to abnormal proliferation of the NE
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(48). A similar phenotype is observed upon overexpression of the
Pah1 antagonist Dgk1 (diacyglycerol kinase 1) (49). Additionally,
defective insertion of the SPB into the NE in cold-sensitive cells
either overexpressing the SPB component Mps3 or expressing the
dominant negative allele Mps3G186K can be rescued by treatment
with oleic acid, BA, or the sterol biosynthesis inhibitor terbinafine
(50). Lastly, deletion and mutation of genes whose products are
involved in the biogenesis and organization of NPCs and the SPB
have been shown, by using high-throughput screens, to render
cells sensitive to agents that inhibit lipid biosynthesis (see the
Yeast Fitness Database [fitdb.stanford.edu/]). Although the
mechanism of the regulation of lipid composition by such pro-
teins is unknown, it has been proposed that there is a requirement
for modulation of membrane biophysical properties during the
construction of NPCs and also for insertion of the new SPB into
the NE (2, 51, 52).
Considerable additional work will be required to understand
how and when membrane fusion occurs during the complex pro-
cess of NPC assembly. The nature of the sensors involved in rec-
ognizing the need for alteration of membrane biophysical prop-
erties and the mechanism by which the cells control the extent of
these modifications are not known. Our data suggest that Brl1,
Brr6, and Apq12 could play a key role in the local modulation of
nuclear membrane composition that is likely needed for nuclear
membrane fusion and the completion of NPC biogenesis. Some of
the NE abnormalities seen in mutant cells may reflect failure to
successfully fuse the two membranes during NPC construction,
and this could result from defective control of the biophysical
properties of the nuclear membrane.
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